Literature DB >> 30979838

Commensal Escherichia coli Aggravates Acute Necrotizing Pancreatitis through Targeting of Intestinal Epithelial Cells.

Junyuan Zheng1,2, Lihong Lou3, Junjie Fan1, Chunlan Huang1, Qixiang Mei1,2, Jianghong Wu1, Yuecheng Guo1,2, Yingying Lu1, Xingpeng Wang4,2, Yue Zeng4,2.   

Abstract

An increase of Escherichia-Shigella was previously reported in acute necrotizing pancreatitis (ANP). We investigated whether Escherichia coli MG1655, an Escherichia commensal organism, increased intestinal injury and aggravated ANP in rats. ANP was induced by retrograde injection of 3.5% sodium taurocholate into the biliopancreatic duct. Using gut microbiota-depleted rats, we demonstrated that gut microbiota was involved in the pancreatic injury and intestinal barrier dysfunction in ANP. Using 16S rRNA gene sequencing and quantitative PCR, we found intestinal dysbiosis and a significant increase of E. coli MG1655 in ANP. Afterward, administration of E. coli MG1655 by gavage to gut microbiota-depleted rats with ANP was performed. We observed that after ANP induction, E. coli MG1655-monocolonized rats presented more severe injury in the pancreas and intestinal barrier function than gut microbiota-depleted rats. Furthermore, Toll-like receptor 4 (TLR4)/MyD88/p38 mitogen-activated protein (MAPK) and endoplasmic reticulum stress (ERS) activation in intestinal epithelial cells were also increased more significantly in the MG1655-monocolonized ANP rats. In vitro, the rat ileal epithelial cell line IEC-18 displayed aggravated tumor necrosis factor alpha-induced inflammation and loss of tight-junction proteins in coculture with E. coli MG1655, as well as TLR4, MyD88, and Bip upregulation. In conclusion, our study shows that commensal E. coli MG1655 increases TLR4/MyD88/p38 MAPK and ERS signaling-induced intestinal epithelial injury and aggravates ANP in rats. Our study also describes the harmful potential of commensal E. coli in ANP.IMPORTANCE This study describes the harmful potential of commensal E. coli in ANP, which has not been demonstrated in previous studies. Our work provides new insights into gut bacterium-ANP cross talk, suggesting that nonpathogenic commensals could also exhibit adverse effects in the context of diseases.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  acute necrotizing pancreatitis; commensal E. colizzm321990; gut microbiota; intestinal barrier dysfunction; intestinal epithelial cells

Year:  2019        PMID: 30979838      PMCID: PMC6544826          DOI: 10.1128/AEM.00059-19

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  15 in total

1.  The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice.

Authors:  Xueyang Li; Cong He; Nianshuang Li; Ling Ding; Hongyan Chen; Jianhua Wan; Xiaoyu Yang; Liang Xia; Wenhua He; Huifang Xiong; Xu Shu; Yin Zhu; Nonghua Lu
Journal:  Gut Microbes       Date:  2020-06-12

2.  Pretreatment with chitosan oligosaccharides attenuate experimental severe acute pancreatitis via inhibiting oxidative stress and modulating intestinal homeostasis.

Authors:  Qi-Xiang Mei; Jun-Hui Hu; Ze-Hua Huang; Jun-Jie Fan; Chun-Lan Huang; Ying-Ying Lu; Xing-Peng Wang; Yue Zeng
Journal:  Acta Pharmacol Sin       Date:  2021-01-25       Impact factor: 7.169

3.  Paneth Cells Protect against Acute Pancreatitis via Modulating Gut Microbiota Dysbiosis.

Authors:  Yang Fu; Qixiang Mei; Nuoming Yin; Zehua Huang; Baiwen Li; Shengzheng Luo; Binqiang Xu; Junjie Fan; Chunlan Huang; Yue Zeng
Journal:  mSystems       Date:  2022-05-02       Impact factor: 7.324

4.  Bile Acid Supplementation Improves Murine Pancreatitis in Association With the Gut Microbiota.

Authors:  You-Dong Wan; Rui-Xue Zhu; Xin-Ting Pan; Tong-Wen Sun
Journal:  Front Physiol       Date:  2020-06-16       Impact factor: 4.566

Review 5.  Role of gut microbiota on intestinal barrier function in acute pancreatitis.

Authors:  Xue-Yang Li; Cong He; Yin Zhu; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

Review 6.  Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target.

Authors:  Tao Zhang; Guangqi Gao; Hafiz Arbab Sakandar; Lai-Yu Kwok; Zhihong Sun
Journal:  Front Nutr       Date:  2022-02-15

7.  Spatioregional assessment of the gut microbiota in experimental necrotizing pancreatitis.

Authors:  F F van den Berg; F Hugenholtz; M A Boermeester; O Zaborina; J C Alverdy
Journal:  BJS Open       Date:  2021-09-06

8.  Persisting Microbiota and Neuronal Imbalance Following T. gondii Infection Reliant on the Infection Route.

Authors:  Timothy French; Johannes Steffen; Albert Glas; Lisa Osbelt; Till Strowig; Björn H Schott; Thomas Schüler; Ildiko Rita Dunay
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

Review 9.  Gut microbiota in pancreatic diseases: possible new therapeutic strategies.

Authors:  Li-Long Pan; Bin-Bin Li; Xiao-Hua Pan; Jia Sun
Journal:  Acta Pharmacol Sin       Date:  2020-10-22       Impact factor: 7.169

10.  Effects of dietary supplementation with multispecies probiotics on intestinal epithelial development and growth performance of neonatal calves challenged with Escherichia coli K99.

Authors:  Yan-Yan Wu; Cun-Xi Nie; Chunsheng Xu; Rui-Qing Luo; Hong-Li Chen; Jun-Li Niu; Xue Bai; Wenju Zhang
Journal:  J Sci Food Agric       Date:  2022-02-09       Impact factor: 4.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.